Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Prometheus Biosciences, Inc., A Subsidiary Of Merck & Co., Inc. (rahway, New Jersey Usa)

Clinical trials sponsored by Prometheus Biosciences, Inc., A Subsidiary Of Merck & Co., Inc. (rahway, New Jersey Usa), explained in plain language.

Not yet finished but already full! 1 Completed 1

New drug shows promise for scleroderma lung disease in early trial

Disease control Ongoing

This study tests a new drug, tulisokibart, in 154 adults with systemic sclerosis (scleroderma) that has caused lung scarring (interstitial lung disease). The goal is to see if the drug can slow lung damage and improve breathing compared to a placebo. Participants must have had sc…

Phase: PHASE2 • Sponsor: Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) • Aim: Disease control

Last updated May 13, 2026 15:59 UTC